Table 1.

Basic characteristics of patients at baseline (n = 50)

	Ischemic Group (n = 31)	Non-ischemic Group (n = 19)	Total (n = 50)
Gender, n
Male	17 (55%)	7 (49%)	24 (48%)
Female	14 (45%)	12 (51%)	26 (52%)
Age, years	55.8 ± 8.5	55.8 ± 8.4	55.8 ± 8.4
BCVA, logMAR units	0.64 ± 0.34	0.56 ± 0.34	0.61 ± 0.34
Duration of Diabetes, years	10.1 ± 4.5	8.2 ± 4.9	9.4 ± 4.7
Stage of DR, n
Mild NPDR	0 (0)	0 (0)	0 (0)
Moderate NPDR	4 (13%)	3 (16%)	7 (14%)
Severe NPDR	21 (68%)	13 (68%)	34 (68%)
PDR	6 (19%)	3 (16%)	9 (18%)
GHb,%	9.6 ± 2.1	9.7 ± 2.0	9.6 ± 2.0
Complication
Hypertension	7	2	9
Renal Failure	2	2	4
Others	0	1	1
CFT(1 mm), μm	328 ± 109	430 ± 118	367 ± 122
FAZ area, mm2	0.510 ± 0.171	0.364 ± 0.127	0.455 ± 0.171
Vessel Density,%
Superficial (ILM-IPL)	41.1 ± 4.1	44.8 ± 3.2	42.5 ± 4.2
Deep (IPL-OPL)	40.7 ± 4.4	44.8 ± 3.2	41.8 ± 4.3

NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy, GHb glycated hemoglobin